Reports Q1 product revenue $3.3M vs. $1M last year. Reports Q1 license revenue $3M vs. $0 last year. “This quarter marks the next step forward ...

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenu ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q1 2025Management ViewCEO Dave Rosa highlighted the strong performance ...

By now, many have seen the commercials with NBA legend Kareem Abdul-Jabbar explaining the importance of seeing ...

Recent research shows the incredible success of radiofrequency ablation in treating AFib, offering renewed hope for patients.

Triple T offers a faster, safer alternative to surgery, by selectively destroying the small adrenal nodule without removing the adrenal gland.

A revolutionary minimally invasive treatment Triple T offers new hope for primary aldosteronism patients potentially replacing surgery with a faster safer alternative ...

Cryoablation and radiofrequency (RF) ablation can cause damage to non-targeted tissues, such as the pulmonary vein, esophagus and phenic nerve. As a result, PFA has emerged as an appealing alternative ...

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...

Advanced Energy introduces the NCF660 series of CF-rated medical power supplies to simplify design and shorten time to market ...

For patients with small HCC, studies suggest that SBRT may have comparable oncologic outcomes to radiofrequency ablation, but a direct comparison in a randomized trial has not been performed.